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Abstract
Background: Recently, gastrointestinal stromal tumors that have developed outside of the digestive tract have
been reported. These tumors are collectively termed extra-gastrointestinal stromal tumors. Extra-gastrointestinal
stromal tumors can also develop in the liver. Only eight case reports involving primary GIST of the liver have been
published. We report a case and review the literature regarding this disease.
Case presentation: A 70-year-old woman with a past history of gastric cancer visited our hospital for regular
inspection. With extensive radiological imaging, a computed tomography scan revealed a mass with a size of 6.
8 cm in the lateral segment of the liver. 18F-Fluoro-2-deoxyglucose positron emission tomography revealed no
other malignancies except for the liver tumor. Because the lesion was suspected of being a primary malignant
hepatic tumor, lateral segmentectomy was performed. The immunohistochemical analysis supported the diagnosis
of gastrointestinal stromal tumors in the liver. The patient has had no evidence of recurrence during the 10-month
follow-up period; imatinib chemotherapy was not administered.
Conclusions: Primary hepatic gastrointestinal stromal tumors had no characteristics that distinguished them from
ordinary tumors in imaging examinations. Primary gastrointestinal stromal tumors might have developed from
interstitial Cajal-like cells.
Keywords: Gastrointestinal stromal tumors, Extra-gastrointestinal stromal tumors, Primary hepatic tumor, Interstitial
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Background
Gastrointestinal stromal tumors (GISTs) are thought to
arise from the interstitial cells of Cajal (ICCs) located in
the gastrointestinal mesenchyme. The current diagnosis
of GISTs is based on histological and immunohisto-
chemical criteria, the most important of which is the
expression of the receptor tyrosine kinase, KIT (CD117,
c-Kit). GISTs are typically found in the gastrointestinal
tract, including the stomach, small intestine, colorectum,
and esophagus [1–4]. The number of case reports in-
volving GISTs in the extra-gastrointestinal sites have
been increasing. These cases are designated as extra-
gastrointestinal stromal tumors (EGISTs) [5]. However,
ICCs have not been identified in the liver; thus, primary
GISTs occurring in the liver have been evaluated.
From around the year 2000, many groups have
become interested in whether or not ICCs are present
outside of the gastrointestinal tract; peculiar interstitial
cells have been found in the upper and lower urinary
tracts, blood vessels, pancreas, and other sites. Such cells
have been named interstitial Cajal-like cells (ICLCs) [6].
Furthermore, ICLCs have been discovered in human
liver fibrosis by Fu et al. [7]; therefore, primary GISTs
might originate from the liver. We report a rare case of
primary hepatic GIST and a review of the literature.
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Case presentation
A Japanese female patient underwent distal gastrectomy
with regional lymph node dissection for gastric cancer
when she was 63 years old. The cancer was a poorly dif-
ferentiated adenocarcinoma with serosa invasion, and
lymph node involvement was found. However, no liver
tumor was detected during radiological examination at
the initial operation. In addition, extensive microscopic
examination of the resected stomach revealed no GISTs,
with the exception of gastric adenocarcinoma.
Seven years after surgery, an abdominal computed
tomography (CT) scan revealed a 6-cm mass in the left
lateral segment of the liver, and peripheral enhancement
in the arterial phase with a heterogenous appearance
(Fig. 1a, b). The left portal vein and bile ducts in the
lateral segment were not involved. Magnetic resonance
imaging (MRI) showed a well-defined mass with hypoin-
tensity relative to the liver parenchyma on T1-weighted
images (Fig. 2a) and moderate hyperintensity on T2-
weighted images (Fig. 2b). The bile ducts in the left
lateral sector were not dilated. The mass showed hyper-
intensity on diffusion-weighted images. In the late
dynamic and hepatobiliary phases, the hepatic tumor exhib-
ited clear hypointensity on ethoxybenzyl diethylenetria-
minepentaacetic acid-MRI. 18F-Fluoro-2-deoxyglucose (18F-
FDG) positron emission tomography (PET) was performed
to rule out the presence of metastases throughout the
body. The hepatic mass showed 18F-FDG uptake with a
maximum standardized uptake value of 6.3; however, no
other sites of hot 18F-FDG uptake were demonstrated
(Fig. 3). Upper and lower gastrointestinal endoscopic
examinations did not suggest the presence of any
other neoplastic lesions. Laboratory findings including
levels of serum carcinoembryonic antigen, carbohy-
drate antigen 19-9, and alpha-fetoprotein were within
normal limits.
The patient underwent left lateral segmentectomy of
the liver because of the possibility of a primary hepatic
malignancy. Intraoperative findings indicated that the
hepatic tumor was palpable with a hard elastic consistency
and had no lymph node involvement; no gastrointestinal
tumor was found in the abdominal cavity. The hepatic
tumor and the adjacent small intestine adhered firmly to
each other, and thus, combined resection was per-
formed. On gross evaluation, the hepatic tumor was
well circumscribed and measured 6.8 × 5.5 cm. In
cross section, the tumor had a whitish-tan color to
the cut surface and focal necrotic and cystic portions
(Fig. 4). No malignancies were detected in the resected
adjacent small intestine.
Fig. 1 CT scan showing a large and round mass in the left hepatic
lobe. The irregular low-density area resembling a mosaic pattern was
found during the arterial (a) and portal phases (b)
Fig. 2 MRI scan showing a low- and high-intensity tumor on
T1-weighted phase images (a) and T2-weighted phase images
(b), respectively
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Microscopically, the hepatic tumor was composed of
spindle cells with pleomorphic nuclei arranged into
short fascicles. The mitotic count was 35–40 mitoses per
50 high-power fields (HPFs) (Fig. 5a). Immunohisto-
chemical staining for KIT, CD34, S-100, smooth muscle
actin, and desmin was performed. Positive results were
observed for KIT and CD34 (Fig. 5b, c). The pathological
findings indicated the presence of GISTs in the liver.
Fletcher’s risk score indicated advanced-stage disease [1].
Adjuvant therapy such as imatinib was not adminis-
tered continuously because of adverse events involving
general malaise and anorexia. The patient recovered well
from the side effects and exhibited no evidence of recur-
rence during the 10-month follow-up period.
No other tumors except for the hepatic tumor were
identified pre- and intra-operatively in the present case;
moreover, no neoplastic lesions were identified after sur-
gical treatment without chemotherapy. We made a final
diagnosis of primary hepatic GIST.
Fig. 4 Photograph showing the gross appearance of the dissected
tumor. On evaluation, the hepatic tumor was well circumscribed and
measured 6.8 × 5.5 cm
Fig. 5 Photomicrographs of stained tumor sections. Microscopically,
the tumor consisted of spindle cells with pleomorphic nuclei
arranged into fascicles (hematoxylin-eosin stain, ×200) (a).
Immunohistochemically, the tumor cells were diffusely positive
for KIT (b) and CD34 (c) (×200)
Fig. 3 18F-FDG PET image showing avid FDG accumulation in the
left hepatic mass (maximum standardized uptake value = 6.3)
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Discussion
GISTs are specific mesenchymal tumors located in re-
gions of the gastrointestinal tract such as in the stomach
(60–70 %), small intestine (20–25 %), colon and rectum
(5 %), and esophagus (<5 %) [2]. However, in recent
years, GISTs have been reported outside of the gastro-
intestinal tract as apparent primary tumors. They can
also occur in the omentum, mesentery, retroperitoneum,
urinary bladder, ureter, uterus, pancreas, and gall bladder
[8–16]. They are designated as EGISTs [5]. According to
Miettinen and Lasota, the frequency of EGISTs is ≤1 %
of all GISTs of defined origin [17]. A PubMed search
was performed using the keywords: “gastrointestinal
stromal tumors,” “extra-gastrointestinal stromal tumors,”
“primary hepatic tumor,” and limited to reports on hu-
man adults and English and Japanese-language publica-
tions, including case reports. Primary GIST of the liver
is a type of EGIST; only eight previous case studies in-
volving this tumor have been reported in the literature
until 2015 [18–25]. The clinicopathological features and
treatment outcomes of the reported primary hepatic
GISTs, including the present case, are detailed in Table 1.
The patients included six men and three women whose
ages ranged from 17 to 79 years (mean, 56 years). There
was a distinct predominance of male patients. Four of
the nine patients had been asymptomatic, but five had
presented with shortness of breath, abdominal fullness,
loss of appetite, hypochondriac pain, nausea, and indi-
gestion. The tumors ranged in size from 5.1 to 20 cm
with a median size of 9.5 cm. Seven patients had unilo-
bar tumors, and eight patients had solitary tumors in the
liver.
All hepatic GISTs demonstrated hypoattenuation on
CT scans. MRI was performed for three patients, but no
characteristic findings were obtained. 18F-Fluorodeoxy-
glucose positron emission tomography (18FDG-PET) was
performed in three patients, and high accumulation of
18FDG was found in their hepatic tumors. All patients
had undergone surgery, with the exception of only one
who had been treated with radiofrequency ablation.
Morphologically, GISTs can be subdivided into spin-
dle cells, epithelioid cells, and mixed types. Seven of
the nine cases were the spindle cell type, one was
the epithelioid cell type, and one was the mixed cell
type.
The mitotic count in the tumor ranged from 0 to 75
per 50 HPFs, with a median of 20 per 50 HPFs.
Fletcher et al. [1] proposed a “risk of aggressive be-
havior” classification of GISTs based only on the
tumor size and HPF mitotic count. The risk stratifica-
tion divides tumors into very low-, low-, intermedi-
ate-, and high-risk categories based on size (<2, 2–5,
5–10, and >10 cm) and on the number of mitoses
per 50 HPFs, typically reported as <5, 5–10, or >10.
The mitotic counts were associated with the recur-
rence and metastasis of the disease. According to a
classification that estimated the risk of aggressive be-
havior, five of nine cases showed high-risk tumors, in-
cluding the present case. The histopathological and
immunohistochemical characteristics of EGISTs are
similar to those of GISTs [23]. Five cases had high
mitotic counts of over 20 per 50 HPFs and, with the
exception of the present case, had developed metasta-
ses or recurrence.
Four patients had received imatinib chemotherapy,
one patient underwent adjuvant therapy, two of
three patients with recurrence were effectively
treated and remained alive for 36 and 66 months,
and the other patient died of the disease. Patients
with recurrent tumors could be expected to achieve
long-term survival if they had received chemother-
apies continuously.
The present case can be considered a primary hepatic
GIST because of the following two findings. First, pre-
operative gastroscopy and colonoscopy imaging studies
and extensive pathological examination of the resected
stomach failed to detect any other GISTs, except for a
hepatic tumor. Second, there was no evidence of recur-
rence and no neoplastic lesions after hepatectomy in the
absence of adjuvant chemotherapy. ICCs are normally
present in the myenteric plexus of the gastrointestinal
tract, and they have not been identified in the liver. Con-
sequently, is it possible that primary GISTs can occur in
the liver? We initially suspected that primary hepatic
GISTs might originate from the biliary system in the
liver. Ahmadi et al. reported that ICCs were identified in
the extrahepatic bile ducts [10]; unfortunately, the exist-
ence of ICCs was not recognized in intrahepatic bile
ducts. However, Popescu et al. demonstrated that ICCs
are present in human exocrine pancreas; such cells were
named pancreatic ICC and later called ICLCs [8]. Subse-
quently, ICLCs were identified in many sites such as the
following: the upper and lower urinary tracts, blood ves-
sels, pancreas, male and female reproductive tracts,
mammary glands, placenta, the heart, and the gut. Re-
cently, ICLCs have been mostly referred to as telocytes
(TCs) [6]. Padhi et al. reviewed 19 reported cases of pan-
creatic extra-gastrointestinal stromal tumors and con-
cluded that with the discovery and characterization of
pancreatic TCs, the origin of stromal tumors reminis-
cent of GIST seemed a real possibility [26]. Further-
more, Fu et al. have reported that TCs were identified
in the liver and were diminished in liver fibrosis [7].
Regardless, TCs have not been identified in the nor-
mal liver; primary GISTs might have developed from
TCs in the liver. Further investigations regarding the
relationship between hepatic GISTs and TCs are
necessary.
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Table 1 The clinicopathological findings and treatment outcomes of reported cases of primary hepatic gastrointestinal stromal tumors
Author Year Age Sex Presentation Location Size
(cm)










1 Hu et al.
[18]
2003 79 F Shortness
of breath












2009 30 M Abdominal
fullness
Bilateral lobe >10 Mixed 75 Low NA NA (1) L-Trisegmentec
tomy
(2) Partial HTx and
gastrectomy















2009 17 M Asymptom Anterior
segment




2010 70 M Loss of
appetite
Left lobe 20 Epithelioid 1 Low NA NA L-HTx NED (NA) NA
6 Bo et al.
[23]
2014 56 M Asymptom Right lobe 9.5 Spindle <5 Low High/low
/−/−
NA Central HTx NED (none) Alive
(12 months)
7 Louis et al.
[24]









8 Kim et al.
[25]







































Primary GIST of the liver is very rare, and only eight
cases have been previously reported. Primary hepatic
GISTs had no characteristics to distinguish them from
ordinary ones on CT and MRI scans and also regarding
histopathological findings. Primary hepatic GISTs might
have developed from ICLCs, but further investigations
are necessary.
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